title: [What's new in recurrent pericarditis in 2011?].
abstract: Recurrent pericarditis are common and their management remains a matter of debate. Their precise pathophysiology is unclear, and both innate and adaptative immunity seem involved. An extensive work-up seeking for etiology seems to be unnecessary during the first episode of acute pericarditis, whereas it is mandatory in recurrent pericarditis. Despite extensive investigations, up to 80 % of recurrent pericarditis remains of unknown origin. Colchicin associated to non steroidal antiinflammatory drugs is the first line treatment whereas immunosuppressive drugs are exceptionally required.
authors: Service de médecine interne II, hôpital Pitié-Salpêtrière, AP-HP, Paris cedex 13, France.
authors: G
authors: G
authors: Geri
authors: P
authors: P
authors: Cacoub
mesh_terms: D000208:Acute Disease; D000465:Algorithms; D001241:Aspirin / Q000008:administration & dosage; D003078:Colchicine / Q000008:administration & dosage; D018450:Disease Progression; D006801:Humans; D010493:Pericarditis / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D012008:Recurrence; D059039:Standard of Care
chemical_list: D001241:Aspirin; D003078:Colchicine